The earnings transcript for Merck & Co., Inc. presents several key points that are likely to influence the stock price in the short term:

1. **Strong Quarterly Performance**: Merck reported exceptional third-quarter results, with total company revenues increasing by 15% year-over-year, driven by strong growth in oncology, vaccines, and Animal Health. KEYTRUDA sales exceeded $3 billion for the first time, and other key products like Lynparza and Lenvima also showed significant growth[3%.

2. **Guidance Update**: The company raised its full-year revenue and non-GAAP EPS guidance, indicating confidence in its business performance. The revised guidance includes a negative impact from foreign exchange but still reflects strong growth[3].

3. **Product Pipeline and Approvals**: Merck highlighted several significant approvals and advancements in its pipeline, including KEYTRUDA combinations and approvals in various indications. This reinforces the company's innovation-led strategy and its potential for sustained growth[3].

4. **Operating Margins and Cost Management**: Despite increased investment in R&D, Merck achieved strong operating margin expansion in the third quarter. However, the company anticipates some pressure on margins in 2020 due to ongoing investments and pricing pressures[3].

5. **Competitive Landscape**: Management expressed confidence in KEYTRUDA's market position, despite potential competitive threats from other immunotherapy combinations. The company's first-mover advantage and strong real-world data support its market leadership[3].

Given these points:

- **Strong financial performance** and raised guidance will likely be viewed positively by investors.
- **Continued innovation** and pipeline progress are key drivers of long-term value.
- **Confidence in market position** despite competitive threats suggests stability.

### Conclusion:
The overall positive tone of the earnings call, strong financial results, and robust pipeline advancements suggest a positive impact on the stock price in the short term.

### Rating:
[1]